Salín-Pascual R, de la Fuente J R, Fernández-Guardiola A
J Clin Psychiatry. 1985 Dec;46(12):528-31.
The antihypertensive drug clonidine was given in an open trial to two treatment-resistant (psychostimulants and tricyclic antidepressants) narcoleptic patients. When given acutely, clonidine suppressed REM sleep. However, patients became tolerant after repeated doses but did not lose the drug's beneficial clinical effects. This suggests that REM suppression may not be necessary for improvement in narcolepsy. Assessments of both clinical and polysomnographic variables before and after the trial indicate that clonidine may have a place in the treatment of some patients with narcolepsy.
在一项开放性试验中,给两名难治性(对精神兴奋剂和三环类抗抑郁药耐药)发作性睡病患者使用了抗高血压药物可乐定。急性给药时,可乐定可抑制快速眼动睡眠(REM睡眠)。然而,患者在重复给药后产生了耐受性,但并未失去该药的有益临床效果。这表明,发作性睡病病情改善可能并不需要抑制REM睡眠。试验前后对临床和多导睡眠图变量的评估表明,可乐定在某些发作性睡病患者的治疗中可能占有一席之地。